Contents
Academic literature on the topic 'MED/27 - NEUROCHIRURGIA'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'MED/27 - NEUROCHIRURGIA.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Dissertations / Theses on the topic "MED/27 - NEUROCHIRURGIA"
ROCA, ELENA. "BRAIN RETRACTION: dynamic-mechanical characterization of brain tissue and development of novel devices." Doctoral thesis, Università degli studi di Brescia, 2023. https://hdl.handle.net/11379/568965.
Full textBackground. La retrazione cerebrale svolge un ruolo importante nella chirurgia cranica, ma i problemi che possono derivare da un'eccessiva retrazione non sono trascurabili. Il principale limite all'uso dei divaricatori cerebrali è la loro elevata possibilità di danno del parenchima: questo diventa particolarmente evidente negli interventi di tante ore che richiedono una retrazione di lunga durata. Possibili lesioni da retrazione cerebrale possono includere contusioni, ematomi ed emorragie che possono anche influenzare l’outcome del paziente. Obiettivi del progetto. Il primo nostro obiettivo era quello di studiare gli strumenti attualmente presenti per la retrazione cerebrale analizzandone vantaggi e svantaggi. Successivamente, l'obiettivo principale era creare un nuovo strumento di retrazione cerebrale e convalidarne l'uso nella chirurgia cranica. Un altro obiettivo era quello di sfruttare la visione endoscopica anche nella chirurgia transcranica progettando camere di lavoro perfettamente adatte per introdurre facilmente l'endoscopio fornendo al contempo una retrazione sicura per il cervello circostante. Per raggiungere questi risultati è stato quindi necessario condurre un accurato studio in fase preclinica con la collaborazione di un team multidisciplinare. Attività di ricerca e novità del progetto. L'attento studio di questo argomento, i test eseguiti in laboratorio di anatomia e di ingegneria, hanno permesso di creare nuovi strumenti tecnologici con molti vantaggi in campo neurochirurgico. La caratterizzazione meccanica dinamica del cervello permette di predire il comportamento meccanico del cervello umano sano e malato potendo anche prevedere ed eventualmente evitare complicanze per i pazienti. Grazie al progresso tecnologico nel campo della neurochirurgia, oggi la necessità di comprendere la correlazione tra la struttura del materiale e le relative proprietà viscoelastiche sta diventando sempre più cruciale anche al fine di sviluppare linee guida progettuali per la prossima generazione di biomateriali, per abbinare tessuti ed extra meccanica della matrice cellulare per modelli tissutali in vitro e applicazioni nella medicina rigenerativa. Conclusioni e prospettive future. La conoscenza del comportamento del parenchima cerebrale in risposta ad una forza di compressione è quindi importante per comprendere i meccanismi alla base del danno, le soglie pericolose e quindi la possibile prevenzione delle complicanze cerebrali. Quest'ultimo aspetto è stato fondamentale per poter realizzare nuovi strumenti chirurgici “intelligenti” che operino in sicurezza. Abbiamo quindi eseguito test su modellino preclinico, su cadavere e poi anche su animale; abbiamo infine studiato il parenchima cerebrale dal punto di vista istologico documentando il danno visibile causato dalla retrazione cerebrale. Questi steps sono stati fondamentali per poi procedere con la fase clinica sui pazienti: i prossimi passi saranno testare il prototipo della spatola sul paziente in sala operatoria e terminare gli ultimi test preclinici della camera. Confidiamo anche di depositare il brevetto per la nuova spatola entro la fine di quest'anno
DEL, MAESTRO MATTIA. "Development of Dye-Perfused Human Placenta Model for Vascular Microsurgery Training: Preparation Protocol and Validation Testing in Hands-on Courses." Doctoral thesis, Università degli studi di Pavia, 2022. http://hdl.handle.net/11571/1463186.
Full textFIASCHI, PIETRO. "The role of PD-L1 in biological behavior of intracranial meningiomas." Doctoral thesis, Università degli studi di Genova, 2021. http://hdl.handle.net/11567/1053770.
Full textLocatelli, M. "L'approccio endoscopico transnasosfenoidale per la decompressione del nervo ottico : uno studio anatomico." Doctoral thesis, Università degli Studi di Milano, 2008. http://hdl.handle.net/2434/61181.
Full textPACETTI, MATTIA. "Advancements in epilepsy surgery at Gaslini Children’s Hospital 2018-2021." Doctoral thesis, Università degli studi di Genova, 2022. http://hdl.handle.net/11567/1080156.
Full textvan, Ierschot Fleur Céline. "Monitoring of reading and spelling in glioma patients undergoing awake surgery." Doctoral thesis, Università degli studi di Trento, 2018. https://hdl.handle.net/11572/367937.
Full textAcerbi, F. "ATTIVAZIONE PRECOCE DEL PROCESSO INFIAMMATORIO IN UN MODELLO SPERIMENTALE DI EMORRAGIA SUBARACNOIDEA." Doctoral thesis, Università degli Studi di Milano, 2010. http://hdl.handle.net/2434/150101.
Full textvan, Ierschot Fleur Céline. "Monitoring of reading and spelling in glioma patients undergoing awake surgery." Doctoral thesis, University of Trento, 2018. http://eprints-phd.biblio.unitn.it/2834/1/FvI_PhD_thesis.pdf.
Full textd'Avella, Elena. "Comparison of the lateral supraorbital approach and endoscopic endonasal transclival approach to basilar apex aneurysms among other possible applications of the endoscopic endonasal technique to vascular neurosurgery: anatomic and clinical study." Doctoral thesis, Università degli studi di Padova, 2018. http://hdl.handle.net/11577/3422218.
Full textLA, CORTE EMANUELE. "CLINICAL AND MOLECULAR BIO-MARKERS IN SKULL BASE CHORDOMAS." Doctoral thesis, Università degli Studi di Milano, 2019. http://hdl.handle.net/2434/610397.
Full textIntroduction. Skull base chordomas are rare slow-growing neoplasms that arise from notochord. Their morbidity is mainly related to highly aggressive local invasion and resistance to treatments. Due to its heterogeneous appearance and not fully understood clinical and molecular behaviors, the main goal of the present work is to identify clinical and bio-molecular markers as specific prognostic factors that could be used for the management of skull base chordoma patients. Achieving a detailed prognostic signature of skull base chordomas is of paramount importance to personalize the treatment to each specific patient. Moreover, sphingolipids analysis is emerging as a new approach in many cancers and it has never been applied in chordomas. Our aim is to investigate chordoma biological behavior and the role of ceramides production in this context of proliferation and invasion. Patients and Methods. A retrospective review of all the patients diagnosed and treated for a skull base chordoma at the Fondazione IRCCS Istituto Neurologico “Carlo Besta” between January 1992 and December 2017 has been performed. Clinical, radiological, surgical and pathological data have been collected. A prospective collection of frozen surgical specimens has been performed to analyze ceramides species in chordomas. Sphingolipids were extracted from frozen tissues and total ceramides and dihydroceramides were evaluated by liquid chromatography and mass spectrometry. Survival analysis was performed according to Kaplan-Meier method. Univariate comparisons were conducted using Mann-Whitney, Chi-square and exact Fisher test. Simple linear regression and correlation with computation of Pearson coefficients analyses were conducted. Using a logistic regression model, statistically significant predictors were rated based on their odds ratios in order to build a personalized grading scale – the Peri-Operative Chordoma Scale (POCS). Results. Eighty-seven consecutive patients were surgically treated for a skull base chordoma during the period of recruitment. Seventy-eight patients were eligible for the retrospective review. There were 38 males (48.7%) and 40 females (51.3%). The mean follow-up was 69 months (range, 3–233). One-hundred-fourteen surgical operations were performed in the initial recruitment or recurrent setting. The presence of motor deficits in skull base chordoma revealed to be a significant prognostic factor correlating with a worse PFS (p=0.0480). Calcification on KM analysis showed a correlation with better outcomes (OS) compared with tumor lacking any calcification on CT scan (p value=0.0402). The degree of MR contrast enhancement revealed to be a significant and strong prognostic factor in terms of OS and PFS (p≤0.0001 and 0.0010, respectively). Jugular foramen involvement represented a significant prognostic factor with a worse PFS in the cohort of primary skull base chordomas (p=0.0130). The presence of chordoma in the pre-brainstem cistern revealed to be a significant prognostic factor with a worse PFS in the cohort of recurrent skull base chordomas (p=0.0210). Brainstem dislocation represented a significant prognostic factor correlating with a both worse outcome in terms of OS and PFS in the cohort of recurrent skull base chordomas (p=0.0060 and 0.0030). Extent of resection represents a strong prognostic factor according to PFS in the cohort of primary skull base chordomas (p=0.0200). Patients operated by an experienced chordoma surgeon did better in terms of prolonged PFS in the cohort of primary patients (p=0.0340). Development of post-operative complications in primary skull base chordoma patients represented an important prognostic factor related to both OS and PFS (p≤0.0001 and 0.0360, respectively). In the cohort of recurrent chordomas, ∆KPS correlated to both OS and PFS (p=0.0010 and 0.0180, respectively). Moreover, post-operative radiation treatment correlated with prolonged OS (p=0.0020) and PFS (p=0.0100). The following factors were found to be statistically significant predictors of both PFS and OS in the logistic regression model: MR contrast enhancement (intense vs mild/no), preoperative motor deficit (yes vs no) and the development of any post-operative complications (yes vs no). A grading scale was obtained with scores ranging between 0 and 17 (Nagelkerke’s pseudo R2=0.656). The mean total ceramides and dihydroceramides species in primary chordomas were 808.4±451.4 pmol/mg (522.5-1760.2) and 30.7±16.4 pmol/mg (17.6-62.4), respectively. The mean total ceramides and dihydroceramides species in recurrent chordomas were 1488.1±763.8 pmol/mg (540.7-2787.5) and 67.2±45.5 pmol/mg (9.0-145.6), respectively. Total ceramides species were significantly higher in recurrent chordomas that underwent previous surgical resection and radiation therapy in comparison to the primary chordomas (p=0.0496). The mean total ceramides and dihydroceramides species in “intense enhancement” group were 1597.6±737.8 pmol/mg (592.7-2787.5) and 69.1±45.0 pmol/mg (17.8-145.6), respectively. The mean total ceramides and dihydroceramides species in “no or mild enhancement” group were 664.7±120.4 pmol/mg (522.5-826.0) and 31.5±13.6 pmol/mg (17.6-53.6), respectively. Total ceramides and dihydroceramides were significantly higher in “intense enhancement” chordomas in comparison to the “no/mild enhancement” chordomas (p=0.0290 and p=0.0186, respectively). Analyzing the association between ceramides level and MIB-1 within each skull base chordoma patient, total ceramides level showed a strong association (r=0.7257, r2=0.5267) with MIB-1 staining (p=0.0033). Analyzing the association between DHCer level and MIB-1 within each skull base chordoma patient, total DHCer level showed also strong association (r=0.6733, r2= 0.4533) with MIB-1 staining (p= 0.0083). Among the single ceramides species Cer C24:1 (r=0.8814, r2=0.7769, p≤0.0001), DHCer C24:1 (r=0.8429, r2=0.7104, p=0.0002) and DHCer C18:0 (r=0.9426, r2=0.8885, p≤0.0001) levels showed a significant correlation with MIB-1 staining. Final candidate predictive factors that well fitted the regression model were: cer24:1 (r=0.824, p≤0.001), and DHCer C18:0 (r=0.748, p=0.002). Conclusion. Our clinical analysis showed that pre-operative clinical symptoms (motor and cranial nerve deficits), anatomical location (jugular foramen, pre-brainstem cisterns and brainstem dislocation), surgical features (extent of tumor resection and surgeon’s experience), development of post-operative complications and KPS decline represent significant prognostic factors. The degree of MR contrast enhancement significantly correlated to both OS and PFS. We also preliminarily developed the Peri-Operative Chordoma Scale (POCS) to aid the practitioner in the personalized management of patients undergoing potential adjuvant therapies. Our lipid analysis showed ceramides as promising tumoral bio-markers in skull base chordomas. Long and very long chain ceramides, such as Cer C24:1 and DHCer C24:1, may be related to a prolonged tumor survival, aggressiveness and the understanding of their effective biological role will hopefully shed lights on the mechanisms of chordoma radio-resistance, tendency to recur and use of agents targeting ceramide metabolism. Such results should be validated in future larger clinical, in-vitro and in-vivo studies to confirm such intricate link between ceramides and chordoma aggressive behavior.